Research Progress of Anti-VEGF Drug Therapy in Corneal Neovascularization Disease
Guan Wen-ta
Abstract
Guan Wen-ta
Abstract
Corneal neovascularization( CNV) is one of common pathologic changes among corneal diseases,and is also an important cause of visual loss. The current studies indicate that corneal neovascularization is closely related to the regulation and expression of vascular endothelial growth factor( VEGF). With the research and clinical applications of anti-VEGF drugs,it plays an important role in the treatment of CNV pathological caused by cornea diseases. Here is to make a review of several methods of anti-VEGF drugs treatment of CNV.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Corneal neovascularization( CNV) is one of common pathologic changes among corneal diseases,and is also an important cause of visual loss. The current studies indicate that corneal neovascularization is closely related to the regulation and expression of vascular endothelial growth factor( VEGF). With the research and clinical applications of anti-VEGF drugs,it plays an important role in the treatment of CNV pathological caused by cornea diseases. Here is to make a review of several methods of anti-VEGF drugs treatment of CNV.
Key concepts: Corneal neovascularization, Neovascularization, Medicine, Cornea, Pathological, Vascular endothelial growth factor, Choroidal neovascularization, VEGF receptors